Limited sampling strategy to predict the area under the curve of tacrolimus in Mexican renal transplant pediatric patients receiving Prograf ® or non‐innovator formulations-Reference-Cited by-同舟云学术

Limited sampling strategy to predict the area under the curve of tacrolimus in Mexican renal transplant pediatric patients receiving Prograf ® or non‐innovator formulations

Published:2019-10 Issue:8 Volume:23 Page:
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Medina‐Aymerich Lorena¹²^ORCID,González‐Ramírez Rodrigo¹^ORCID,García‐Roca Pilar²^ORCID,Reyes Herlinda³,Hernández Ana María²,Medeiros Mara²⁴^ORCID,Castañeda‐Hernández Gilberto¹^ORCID

Affiliation:

1. Departamento de Farmacología Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional Ciudad de México Mexico

2. Unidad de Investigación y Diagnóstico en Nefrología y Metabolismo Mineral Óseo Hospital Infantil de México Federico Gómez Ciudad de México Mexico

3. Laboratorio Central Hospital Infantil de México Federico Gómez Ciudad de México Mexico

4. Departamento de Farmacología Facultad de Medicina Universidad Nacional Autónoma de México Ciudad de México Mexico

Funder

Consejo Nacional de Ciencia y Tecnología

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/petr.13595

Reference41 articles.

1. Immunosuppressive Drugs for Kidney Transplantation

2. Drug Insight: maintenance immunosuppression in kidney transplant recipients

3. Mode of Action of Tacrolimus (FK506): Molecular and Cellular Mechanisms

4. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data

5. Clinical Pharmacokinetics of Tacrolimus

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tacrolimus population pharmacokinetics in adult heart transplant patients;British Journal of Clinical Pharmacology;2023-08-10

2. Evaluation of limited-sampling strategies to calculate AUC(0–24) and the role of CYP3A5 in Chilean pediatric kidney recipients using extended-release tacrolimus;Frontiers in Pharmacology;2023-03-14

3. Addressing the Ethical Challenges of Providing Kidney Failure Care for Children: A Global Stance;Frontiers in Pediatrics;2022-03-11

4. Appreciating the Impact of Tacrolimus Sampling Time Deviations in Pediatric Patients With Nephrotic Syndrome;Therapeutic Drug Monitoring;2020-06